Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2023-06-06 00:00:00 ET · period of report 2023-06-02 · accession 0000899243-23-014615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-06 | 2023-06-02+ | VRDN | Meisner Lara | CLO | M - OptEx | $17.38 | +7,500 | 30.5K | +33% | +$130.4K |
| DM | 2023-06-06 | 2023-06-02+ | VRDN | Meisner Lara | CLO | S - Sale+OE | $24.82 | -7,500 | 30.0K | -20% | -$186.1K |
| DM | 2023-06-06 | 2023-06-02+ | VRDN | Meisner Lara | CLO | M - OptEx | $0.00 | -7,500 | 18.1K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-02 | M | A | 1,875 | $14.00 | 31,846 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-02 | S | D | 1,875 | $24.21 | 29,971 | D | — | — | (F1) This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 7, 2023 (the "Plan") in multiple trades at prices ranging from $23.89 to $24.61. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-06-06 | S | D | 5,126 | $25.02 | 29,971 | D | — | — | (F3) This transaction was executed pursuant to the Plan in multiple trades at prices ranging from $25.00 to $25.155. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2023-06-05 | S | D | 499 | $25.03 | 29,971 | D | — | — | (F2) This transaction was executed pursuant to the Plan in multiple trades at prices ranging from $25.02 to $25.035. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2023-06-06 | M | A | 5,126 | $18.51 | 35,097 | D | — | — | |
| 6 | Common | Common Stock | 2023-06-05 | M | A | 499 | $18.51 | 30,470 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-06-06 | M | D | 5,126 | $0.00 | 84,375 | D | $18.51 · — to 2032-02-02 | 5,126 Common Stock | (F5) This option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-06-05 | M | D | 499 | $0.00 | 89,501 | D | $18.51 · — to 2032-02-02 | 499 Common Stock | (F5) This option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-06-02 | M | D | 1,875 | $0.00 | 18,128 | D | $14.00 · — to 2031-09-22 | 1,875 Common Stock | (F4) The option vested 25% on September 22, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. |